Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Filings indexed 448 across all filing types
Latest filing 2025-09-29 Regulatory Filings
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice from Orchid Pharma Limited regarding the closure of the trading window for insiders ahead of the announcement of the company's unaudited limited reviewed financial results for the quarter ending September 30, 2025. It references regulatory compliance with SEBI regulations on insider trading and informs stakeholders about the trading restrictions during the period before the financial results are declared. The document does not contain any financial statements or detailed financial data itself, nor does it announce the results. It is an announcement related to trading restrictions in anticipation of a financial report. Given the nature and length of the document (2722 characters), it is not a full financial report but a regulatory announcement about trading window closure. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-09-29 English
Shareholders meeting
Regulatory Filings
2025-09-22 English
Shareholders meeting
Regulatory Filings
2025-09-22 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Summary Proceedings of the 32nd Annual General Meeting (AGM) of Orchid Pharma Limited held on September 20, 2025.' It details the attendance, procedural aspects, resolutions proposed and passed, and voting procedures at the AGM. It includes information about the Chairman, Directors, Auditors, and the business transacted at the meeting. There is no full financial report or detailed financial statements included, but rather a summary of the meeting proceedings. This matches the definition of 'AGM Information' which covers presentations and materials shared during the AGM. The document is over 10,000 characters, so it is not a brief announcement or a report publication announcement. Therefore, the correct classification is AGM Information (AGM-R).
2025-09-20 English
Corrigendum
AGM Information Classification · 95% confidence The document is a corrigendum to the Notice of the 32nd Annual General Meeting (AGM) of Orchid Pharma Limited for the financial year 2024-25. It references the original AGM Notice and provides corrections to the text of Item No. 8 of the Special Business. The document includes details about the meeting date, resolutions to be passed, explanatory statements, and procedural information related to the AGM. It does not contain the full annual report or financial statements themselves but rather updates and corrections to the AGM notice. The document is lengthy (15,000 characters) and contains detailed information about the AGM agenda and resolutions, which aligns with materials shared during an AGM. Therefore, the document fits the category of AGM Information (AGM-R).
2025-09-11 English
General Updates
Regulatory Filings
2025-08-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.